Published in Phys Med Biol on August 06, 2009
Magnetic nanoparticle hyperthermia enhancement of cisplatin chemotherapy cancer treatment. Int J Hyperthermia (2013) 1.00
Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles. ACS Nano (2011) 0.95
Molecular thermometry. Pediatr Res (2010) 0.92
Thermal potentiation of chemotherapy by magnetic nanoparticles. Nanomedicine (Lond) (2013) 0.89
Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy. J Nanobiotechnology (2011) 0.87
Antitumor effect and toxicity of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles in mice bearing breast cancer. J Nanobiotechnology (2013) 0.87
Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors. ACS Nano (2013) 0.87
Nanoparticle formulations of cisplatin for cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.85
Antitumor effect of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles on mice bearing breast cancer: a systemic toxicity assay. Tumour Biol (2014) 0.79
Functionalized milk-protein-coated magnetic nanoparticles for MRI-monitored targeted therapy of pancreatic cancer. Int J Nanomedicine (2016) 0.76
Combination of graphene oxide-silver nanoparticle nanocomposites and cisplatin enhances apoptosis and autophagy in human cervical cancer cells. Int J Nanomedicine (2017) 0.75
Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials (2007) 3.12
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer (2010) 2.62
Impact of cryopreservation on extracellular matrix structures of heart valve leaflets. Ann Thorac Surg (2006) 2.35
Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia (2005) 2.18
Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine (Baltimore) (2009) 2.14
Prevalence of PB1-F2 of influenza A viruses. J Gen Virol (2007) 1.88
Targeted delivery of magnetic aerosol droplets to the lung. Nat Nanotechnol (2007) 1.86
Magnetic particle hyperthermia--a promising tumour therapy? Nanotechnology (2014) 1.73
Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils. Proc Natl Acad Sci U S A (2007) 1.68
The magnetofection method: using magnetic force to enhance gene delivery. Biol Chem (2003) 1.66
Thermal ablation of tumors using magnetic nanoparticles: an in vivo feasibility study. Invest Radiol (2002) 1.61
Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target (2003) 1.58
Targeting cancer cells: magnetic nanoparticles as drug carriers. Eur Biophys J (2006) 1.52
Validity limits of the Néel relaxation model of magnetic nanoparticles for hyperthermia. Nanotechnology (2009) 1.50
Magnetic multicore nanoparticles for hyperthermia--influence of particle immobilization in tumour tissue on magnetic properties. Nanotechnology (2011) 1.49
False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study. AJR Am J Roentgenol (2010) 1.42
Assessment of skeletal age at the wrist in children with a new ultrasound device. Pediatr Radiol (2005) 1.35
Diffusion tensor imaging: the normal evolution of ADC, RA, FA, and eigenvalues studied in multiple anatomical regions of the brain. Neuroradiology (2009) 1.33
Hepatic excretory function in sepsis: implications from biophotonic analysis of transcellular xenobiotic transport in a rodent model. Crit Care (2013) 1.29
Differentiation of phyllodes breast tumors from fibroadenomas on MRI. AJR Am J Roentgenol (2005) 1.27
Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis. PLoS Med (2012) 1.27
Enhanced leukemia cell detection using a novel magnetic needle and nanoparticles. Cancer Res (2009) 1.17
Magnetofection: enhancing and targeting gene delivery with superparamagnetic nanoparticles and magnetic fields. J Liposome Res (2003) 1.16
Potential MRI interpretation model: differentiation of benign from malignant breast masses. AJR Am J Roentgenol (2005) 1.15
Benefit of a 17-year long-term bisphosphonate therapy in a patient with Gorham-Stout syndrome. Arch Orthop Trauma Surg (2008) 1.15
Wallerian degeneration of pyramidal tract after paramedian pons infarct. Cerebrovasc Dis (2010) 1.15
Characterization of magnetite nanoparticles for SQUID-relaxometry and magnetic needle biopsy. J Magn Magn Mater (2009) 1.14
Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells. Eur Radiol (2004) 1.12
Current knowledge on PB1-F2 of influenza A viruses. Med Microbiol Immunol (2010) 1.12
Influence of breast lesion size and histologic findings on tumor detection rate of a computer-aided detection system. Radiology (2003) 1.11
Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles. Proc Natl Acad Sci U S A (2008) 1.08
Cortical blindness after contrast-enhanced CT: complication in a patient with diabetes insipidus. AJNR Am J Neuroradiol (2003) 1.07
Early diagnosis of cerebral involvement in Sturge-Weber syndrome using high-resolution BOLD MR venography. Pediatr Radiol (2004) 1.05
A technical triade for proteomic identification and characterization of cancer biomarkers. Cancer Res (2004) 1.05
Influence of image-capturing parameters on digital X-ray radiogrammetry. J Clin Densitom (2005) 1.04
High therapeutic efficiency of magnetic hyperthermia in xenograft models achieved with moderate temperature dosages in the tumor area. Pharm Res (2014) 1.03
Heating potential of iron oxides for therapeutic purposes in interventional radiology. Acad Radiol (2002) 1.03
Discovery and identification of alpha-defensins as low abundant, tumor-derived serum markers in colorectal cancer. Gastroenterology (2005) 1.03
Further signs in the evaluation of magnetic resonance mammography: a retrospective study. Invest Radiol (2005) 1.02
Cryotherapy of breast cancer under ultrasound guidance: initial results and limitations. Eur Radiol (2002) 1.02
In vivo imaging of experimental arthritis with near-infrared fluorescence. Arthritis Rheum (2004) 1.02
Time course of diffusion imaging in acute brainstem infarcts. J Magn Reson Imaging (2007) 1.01
Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients. J Lipid Res (2012) 1.01
Use of a SQUID array to detect T-cells with magnetic nanoparticles in determining transplant rejection. J Magn Magn Mater (2007) 1.00
Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes. Acta Radiol (2010) 1.00
Magnetic nanoparticle heating and heat transfer on a microscale: Basic principles, realities and physical limitations of hyperthermia for tumour therapy. Int J Hyperthermia (2013) 0.99
Ultrasound-guided, percutaneous cryotherapy of small (< or = 15 mm) breast cancers. Invest Radiol (2005) 0.99
Diffusion tensor magnetic resonance imaging of the breast: a pilot study. Eur Radiol (2010) 0.99
Time-resolved functional 1H MR spectroscopic detection of glutamate concentration changes in the brain during acute heat pain stimulation. Neuroimage (2009) 0.99
The adjacent vessel sign on breast MRI: new data and a subgroup analysis for 1,084 histologically verified cases. Korean J Radiol (2010) 0.98
Resolving arterial phase and temporal enhancement characteristics in DCE MRM at high spatial resolution with TWIST acquisition. J Magn Reson Imaging (2011) 0.97
Iron oxide-based nanostructures for MRI and magnetic hyperthermia. Nanomedicine (Lond) (2012) 0.97
Demonstration of paramagnetic and diamagnetic cerebral lesions by using susceptibility weighted phase imaging (SWI). Z Med Phys (2006) 0.96
Diagnosis of arthritis using near-infrared fluorochrome Cy5.5. Invest Radiol (2004) 0.93
Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions. Eur Radiol (2009) 0.93
MR Imaging in Wegener granulomatosis of the spinal cord. AJNR Am J Neuroradiol (2003) 0.93
Radio-frequency tumor ablation: internally cooled electrode versus saline-enhanced technique in an aggressive rabbit tumor model. Radiology (2002) 0.92
Neuronal prostaglandin E2 receptor subtype EP3 mediates antinociception during inflammation. Proc Natl Acad Sci U S A (2013) 0.92
Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion. Carcinogenesis (2009) 0.92
Computerized quantification of joint space narrowing and periarticular demineralization in patients with rheumatoid arthritis based on digital x-ray radiogrammetry. Invest Radiol (2006) 0.92
Normative data for digital X-ray radiogrammetry from a female and male German cohort. J Clin Densitom (2006) 0.91
Minimal-invasive magnetic heating of tumors does not alter intra-tumoral nanoparticle accumulation, allowing for repeated therapy sessions: an in vivo study in mice. Nanotechnology (2011) 0.91
In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice. Radiology (2008) 0.91
Computerized digital imaging techniques provided by digital X-ray radiogrammetry as new diagnostic tool in rheumatoid arthritis. J Digit Imaging (2006) 0.90
T lymphocytes as potential therapeutic drug carrier for cancer treatment. Int J Pharm (2006) 0.90
Differential diagnosis of breast lesions 5 mm or less: is there a role for magnetic resonance imaging? J Comput Assist Tomogr (2010) 0.90
Bioelectromagnetic field effects on cancer cells and mice tumors. Electromagn Biol Med (2010) 0.89
Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study. Eur Radiol (2008) 0.89
Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res (2004) 0.89
An in vitro characterization study of new near infrared dyes for molecular imaging. Eur J Med Chem (2009) 0.88
Voiding urosonography with ultrasonography contrast medium in children. Pediatr Nephrol (2002) 0.88
Computer-aided joint space analysis of the metacarpal-phalangeal and proximal-interphalangeal finger joint: normative age-related and gender-specific data. Skeletal Radiol (2007) 0.88
Magnetic resonance-guided large-core breast biopsy inside a 1.5-T magnetic resonance scanner using an automatic system: in vitro experiments and preliminary clinical experience in four patients. Invest Radiol (2005) 0.88
Fluorescent bacterial magnetic nanoparticles as bimodal contrast agents. Invest Radiol (2007) 0.88
Application of MR mammography beyond local staging: is there a potential to accurately assess axillary lymph nodes? evaluation of an extended protocol in an initial prospective study. AJR Am J Roentgenol (2011) 0.88
Fluorescent liposomes as contrast agents for in vivo optical imaging of edemas in mice. Small (2008) 0.87
Quantification of specific bindings of biomolecules by magnetorelaxometry. J Nanobiotechnology (2008) 0.87
Combined magnetic resonance imaging of deep venous thrombosis and pulmonary arteries after a single injection of a blood pool contrast agent. Eur Radiol (2010) 0.87
US and MRI of gastrointestinal graft-versus-host disease. Pediatr Radiol (2002) 0.87
Effect of contrast agent on the results of in vivo ¹H MRS of breast tumors - is it clinically significant? NMR Biomed (2011) 0.87
Acute chest pain, heart failure, and eosinophilia in a woman without coronary disease. Cardiovasc Intervent Radiol (2009) 0.86
Characteristics of ductal carcinoma in situ in magnetic resonance imaging. Clin Imaging (2007) 0.86
Effect of breast density on computer aided detection. J Digit Imaging (2005) 0.86
The adjacent vessel on dynamic contrast-enhanced breast MRI. AJR Am J Roentgenol (2006) 0.86
Focal transitional mastitis in MR-mammography: preliminary findings. Eur J Radiol (2012) 0.86
Diffusion tensor imaging in children and adolescents with tuberous sclerosis. Pediatr Radiol (2005) 0.86
Suitable labels for molecular imaging--influence of dye structure and hydrophilicity on the spectroscopic properties of IgG conjugates. Bioconjug Chem (2011) 0.86
Normative reference values of joint space width estimated by computer-aided joint space analysis (CAJSA): the distal interphalangeal joint. J Digit Imaging (2007) 0.85
The exposure of cancer cells to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levels. Int J Nanomedicine (2013) 0.85